Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,263 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ischaemic cardiac outcomes in patients with atrial fibrillation treated with vitamin K antagonism or factor Xa inhibition: results from the ROCKET AF trial.
Mahaffey KW, Stevens SR, White HD, Nessel CC, Goodman SG, Piccini JP, Patel MR, Becker RC, Halperin JL, Hacke W, Singer DE, Hankey GJ, Califf RM, Fox KA, Breithardt G; ROCKET AF Investigators. Mahaffey KW, et al. Among authors: patel mr. Eur Heart J. 2014 Jan;35(4):233-41. doi: 10.1093/eurheartj/eht428. Epub 2013 Oct 15. Eur Heart J. 2014. PMID: 24132190 Free PMC article. Clinical Trial.
Clinical trial issues in weight-loss therapy.
Patel MR, Donahue M, Wilson PW, Califf RM. Patel MR, et al. Am Heart J. 2006 Mar;151(3):633-42. doi: 10.1016/j.ahj.2005.03.006. Am Heart J. 2006. PMID: 16504625 Review.
Rivaroxaban, an oral direct factor Xa inhibitor.
Piccini JP, Patel MR, Mahaffey KW, Fox KA, Califf RM. Piccini JP, et al. Among authors: patel mr. Expert Opin Investig Drugs. 2008 Jun;17(6):925-37. doi: 10.1517/13543784.17.6.925. Expert Opin Investig Drugs. 2008. PMID: 18491993 Review.
Transfusion and mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Jolicoeur EM, O'Neill WW, Hellkamp A, Hamm CW, Holmes DR Jr, Al-Khalidi HR, Patel MR, Van de Werf FJ, Pieper K, Armstrong PW, Granger CB; APEX-AMI Investigators. Jolicoeur EM, et al. Among authors: patel mr. Eur Heart J. 2009 Nov;30(21):2575-83. doi: 10.1093/eurheartj/ehp279. Epub 2009 Jul 11. Eur Heart J. 2009. PMID: 19596659 Clinical Trial.
Quality of care for atrial fibrillation among patients hospitalized for heart failure.
Piccini JP, Hernandez AF, Zhao X, Patel MR, Lewis WR, Peterson ED, Fonarow GC; Get With The Guidelines Steering Committee and Hospitals. Piccini JP, et al. Among authors: patel mr. J Am Coll Cardiol. 2009 Sep 29;54(14):1280-9. doi: 10.1016/j.jacc.2009.04.091. J Am Coll Cardiol. 2009. PMID: 19778670 Free article.
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.
Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KA, Califf RM; ROCKET AF Investigators. Patel MR, et al. N Engl J Med. 2011 Sep 8;365(10):883-91. doi: 10.1056/NEJMoa1009638. Epub 2011 Aug 10. N Engl J Med. 2011. PMID: 21830957 Free article. Clinical Trial.
Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment.
Fox KA, Piccini JP, Wojdyla D, Becker RC, Halperin JL, Nessel CC, Paolini JF, Hankey GJ, Mahaffey KW, Patel MR, Singer DE, Califf RM. Fox KA, et al. Among authors: patel mr. Eur Heart J. 2011 Oct;32(19):2387-94. doi: 10.1093/eurheartj/ehr342. Epub 2011 Aug 28. Eur Heart J. 2011. PMID: 21873708 Clinical Trial.
Stroke prevention in atrial fibrillation.
Piccini JP, Wallace TW, Patel MR, Becker RC. Piccini JP, et al. Among authors: patel mr. Cardiovasc Drugs Ther. 2011 Dec;25(6):561-70. doi: 10.1007/s10557-011-6334-4. Cardiovasc Drugs Ther. 2011. PMID: 21927837 Review. No abstract available.
1,263 results